Lexaria provides update on 5 studies focussed on DehydraTECH CBD as a treatment for hypertension



Lexaria Bioscience (CSE: LXX-NASDAQ: LEXX- OTC: LXRP) CEO Chris Bunka joined Steve Darling from Proactive to share details about the company’s three …